SCHEMBL14686148

SCHEMBL14686148

COc1ccc(Nc2cc(N)c3nc([C@H]4CC[C@H](N)CC4)cn3n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 3/20 0.40
▸ GAA P10253 3/20 0.40
▸ MAPT P10636 3/20 0.40
▸ POLB P06746 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ GALR2 O43603 4/20 0.39
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ MAT2A P31153 1/20 0.37
▸ MAPK8 P45983 1/20 0.37
▸ MAPK9 P45984 1/20 0.37
▸ MAPK10 P53779 1/20 0.37
▸ MAPK14 Q16539 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.36
▸ HTT P42858 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ HIF1A Q16665 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ BMI1 P35226 1/20 0.36
▸ GALR1 P47211 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5458624 0.89 MAPKAPK2 (0.41) RAB9AGAAMAPTSMN1; SMN2MEN1
SCHEMBL14686295 0.87 MAPT (0.38) GAAMAPTSMN1; SMN2NPSR1KDM4E
SCHEMBL22158559 0.85 MAPKAPK2 (0.39) RAB9AMAPTSMN1; SMN2MEN1KMT2A
SCHEMBL3023055 0.84 MAPK8 (0.38) RAB9AGAAMAPTPOLBSMN1; SMN2
SCHEMBL14686135 0.84 IGF1R (0.35) CCNE1CDK2FLT3
SCHEMBL14686146 0.79 MAPK1 (0.38) RAB9AMAPTMEN1KMT2AMAT2A
SCHEMBL14686217 0.79 EGFR (0.38) RAB9AMAPTFLT3
SCHEMBL14686138 0.78 GALR2 (0.35) RAB9AGAAMAPTPOLBSMN1; SMN2
SCHEMBL14686164 0.76 PIM1 (0.41) GAAMAPTMEN1KMT2ALMNA
SCHEMBL14686229 0.75 EGFR (0.33) MAPTMAPK8MAPK9MAPK10MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1928879-B1 FUSED HETEROCYCLIC COMPOUNDS USEFUL AS KINASE MODULATORS BRISTOL MYERS SQUIBB CO (US) 2013-02-13 — — EP disclosed
Send feedback